GA
BMY icon

Glenhill Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Glenhill Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,703
Closed -$297K – 100
2014
Q1 		$297K Buy
5,703
+2,353
+70% +$125K 0.03% 102
2013
Q4 		$178K Buy
+3,350
New +$171K 0.02% 97

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Glenhill Advisors's BMY Position: Q2 2014 in Review

Glenhill Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2014, closing a stake of 5,703 shares — an estimated $297K sold.

Glenhill Advisors first reported a position in BMY in Q4 2013 and held it in 2 quarters. The position peaked at $297K in Q1 2014. 1,302 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

  • Glenhill Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2014 after selling out during the quarter.
  • Glenhill Advisors sold 5,703 Bristol-Myers Squibb shares in Q2 2014, an estimated $297K.
  • Glenhill Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 2 quarters.
  • Glenhill Advisors's Bristol-Myers Squibb position peaked at $297K in Q1 2014.
  • 1,302 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Glenhill Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.